Whether a thick endometrial lining is worrying depends almost entirely on two things: whether you’ve gone through menopause and whether you have bleeding. In postmenopausal women with vaginal bleeding, an endometrial thickness of 4 mm or less carries a greater than 99% negative predictive value for endometrial cancer, meaning cancer is extremely unlikely. Above that threshold, further testing is typically recommended. If you’re premenopausal, the lining naturally fluctuates throughout your cycle and can measure anywhere from 1 mm to 18 mm without anything being wrong.
Normal Thickness Throughout the Menstrual Cycle
If you’re still having periods, your endometrial lining changes dramatically from week to week. During menstruation, it sheds down to a thin line of about 1 to 4 mm. Through the proliferative phase (roughly days 5 through 14), it rebuilds and develops a layered appearance, reaching 12 to 13 mm by ovulation, with some women measuring up to 16 mm. After ovulation, during the secretory phase, the lining continues to thicken and typically measures 16 to 18 mm.
This means a reading of 15 mm in a premenopausal woman could be completely normal if the ultrasound was done in the second half of her cycle, or potentially concerning if it was taken right after her period ended. Timing matters enormously, and an ultrasound report that doesn’t note where you are in your cycle is missing critical context.
Thresholds After Menopause With Bleeding
Postmenopausal bleeding is the scenario where endometrial thickness matters most. About 9% of postmenopausal women who see a doctor for vaginal bleeding eventually receive an endometrial cancer diagnosis. That number is relatively low, but 90% of women who are diagnosed with endometrial cancer reported bleeding before their diagnosis. So bleeding after menopause always warrants investigation.
The key number is 4 mm. The American College of Obstetricians and Gynecologists states that an endometrial thickness at or below 4 mm in a postmenopausal woman with bleeding has a greater than 99% negative predictive value for cancer. A large meta-analysis of 35 studies and nearly 5,900 women found that using a 5 mm cutoff identified 96% of women with endometrial cancer. In practical terms, if your lining is 4 mm or thinner and you’ve had some spotting, cancer is very unlikely, though your doctor may still monitor you.
Above 5 mm with bleeding, the risk shifts. In a modeled population of 10,000 postmenopausal women with bleeding, the cancer risk was approximately 0.07% when the lining measured 5 mm or less, compared to 7.3% when it exceeded 5 mm. That 7.3% still means the vast majority of women with a thick lining don’t have cancer, but it’s enough to justify a biopsy.
When There’s No Bleeding
Sometimes a thickened endometrium shows up incidentally on an ultrasound or CT scan done for an unrelated reason. This is a different situation from bleeding, and the thresholds are higher. Canadian gynecology guidelines note that in postmenopausal women without bleeding, an endometrium under 11 mm is rarely a serious problem. The same modeled analysis found that in women without bleeding, the cancer risk was about 0.002% when the lining was 11 mm or thinner, rising to 6.7% above 11 mm.
The goal of these higher thresholds is to avoid unnecessary biopsies. An incidentally discovered lining of 6 or 7 mm in a woman with no symptoms is a common finding that rarely leads to a concerning diagnosis.
Medications That Thicken the Lining
Two common medications can significantly affect endometrial thickness and make readings harder to interpret. Tamoxifen, used in breast cancer treatment, typically increases endometrial thickness to 9 to 13 mm in postmenopausal women, compared to 4 to 5.4 mm in women not taking the drug. This thickening is a known side effect and doesn’t automatically indicate disease, though tamoxifen does increase the risk of endometrial changes over time.
Hormone replacement therapy can also push the lining up to about 8 mm in postmenopausal women. Some researchers have suggested that women on hormone therapy should use a higher biopsy threshold of 8 mm rather than the standard 4 to 5 mm, since their baseline is already elevated. If you’re on either of these medications and an ultrasound shows a thick lining, the reading needs to be interpreted in that context.
PCOS and Other Risk Factors
Polycystic ovary syndrome (PCOS) creates a unique situation. Women with PCOS often go months without a period, which means the lining keeps building without the regular shedding that a menstrual cycle provides. In one study of women with PCOS, 21.4% had endometrial hyperplasia (an overgrowth of lining cells that can be a precursor to cancer) and 1.7% had endometrial cancer. Women in that study who had endometrial disease averaged a lining of about 13.5 mm, compared to roughly 8.8 mm in those with normal findings. A cutoff of 8.5 mm had a sensitivity of about 78% for detecting endometrial problems in this group.
Obesity compounds the risk because fat tissue produces estrogen, which stimulates the endometrial lining to grow. The combination of PCOS, obesity, and irregular periods creates an environment where the lining is chronically exposed to estrogen without the counterbalancing effect of progesterone. If you have PCOS and go more than three months without a period, that’s worth discussing with your doctor regardless of what your lining measures.
Benign Causes of a Thick Lining
Most thickened endometrial findings turn out to be noncancerous. Endometrial polyps are one of the most common culprits. These are small growths on the lining that can make the overall measurement appear thicker on ultrasound. Submucosal fibroids, which grow just beneath the lining, can have the same effect. Fluid trapped in the uterine cavity, sometimes seen after menopause when the cervical canal narrows, can also make the lining look thicker than it actually is.
Simple endometrial hyperplasia without atypical cells is another common finding. This overgrowth of lining tissue is usually driven by excess estrogen relative to progesterone and often resolves with progesterone treatment. Hyperplasia with atypical cells is more concerning, as it has a higher chance of progressing to cancer and may require more aggressive management.
What Happens During Testing
The first step is usually a transvaginal ultrasound, which measures the lining’s thickness and can identify obvious abnormalities like polyps or fibroids. However, ultrasound has limitations. Its sensitivity for detecting focal lesions inside the uterus is about 60%, meaning it misses roughly 4 in 10 small growths.
If the lining is above the threshold for your situation, or if you have concerning symptoms, the next step is typically a tissue sample. An office endometrial biopsy is the most common approach. It involves inserting a thin, flexible tube through the cervix to collect a small strip of tissue. The procedure takes a few minutes and can cause cramping similar to menstrual cramps. It’s accurate in about 83% of cases for confirming the final diagnosis, though it can miss focal lesions since it samples blindly.
A more thorough option is hysteroscopy, where a small camera is inserted into the uterus to directly visualize the lining and take targeted biopsies. This is more accurate for polyps and small growths but is more involved. A dilation and curettage (D&C), performed under anesthesia, samples more of the lining and is slightly more accurate for grading abnormalities. In one study comparing the two approaches, the office biopsy underestimated the severity of early-stage endometrial cancer in 17.4% of cases, compared to 8.7% with D&C.
Red-Flag Symptoms to Watch For
Any vaginal bleeding after menopause warrants evaluation, even a single episode of light spotting. Before menopause, the warning signs are subtler: periods that have become significantly heavier, bleeding between periods, or cycles that have become irregular after years of regularity. Watery or blood-tinged discharge outside of your period is another sign worth noting.
A thick lining on its own, found incidentally, is less urgent than a thick lining paired with bleeding. The combination of postmenopausal bleeding and a lining over 4 to 5 mm is the scenario that most reliably identifies women who need prompt biopsy. A thick lining without symptoms in a low-risk woman may simply need a follow-up ultrasound in a few months to see if it changes.